Parmax Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22

Sales

4.47

17.09

5.47

3.69

9.97

Operating profit

-1.84

0.71

-1.42

-0.90

0.75

Interest

0.52

0.24

0.30

0.21

0.19

Gross profit

-2.35

0.59

-1.70

-1.09

0.58

EPS (Rs)

-7.60

-0.55

-6.80

-5.40

-1.51

Other income

0.01

0.12

0.02

0.02

0.02

Stock adjustment

-

-0.34

1.50

-0.46

-0.18

Raw material

3.53

13.61

1.67

1.77

4.54

Power and fuel

-

-

-

-

-

Employee expenses

1.29

1.57

1.57

1.06

1.45

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1.49

1.54

2.15

2.22

3.42

Provisions made

-

-

-

-

-

Depreciation

0.50

0.80

0.85

0.93

0.98

Taxation

-

-

-

-

0.16

Net profit / loss

-2.84

-0.20

-2.55

-2.02

-0.56

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

3.74

3.74

3.74

3.74

3.74

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-41.12

4.16

-25.90

-24.40

7.55

GPM (%)

-52.28

3.46

-30.89

-29.49

5.82

NPM (%)

-63.36

-1.19

-46.39

-54.53

-5.64